Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 13, 2013 - Issue 10
Submit an article Journal homepage
119
Views
10
CrossRef citations to date
0
Altmetric
Theme: Nervous System Neoplasm - Review

Elderly patients with glioblastoma: the treatment challenge

Alba FiorentinoRadiation Oncology Department, IRCCS-CROB, via S. Pio 1, 85028, Rionero in Vulture (PZ), ItalyCorrespondence[email protected]
,
Pasquale De BonisNeurosurgery Department, S. Anna Hospital, Via Aldo Moro 8, 44124 Cona, Ferrara (FE), Italy
,
Silvia ChiesaRadiation Oncology Department, Catholic University of the Sacred Heart, largo A. Gemelli, Roma, Italy
,
Mario BalducciRadiation Oncology Department, Catholic University of the Sacred Heart, largo A. Gemelli, Roma, Italy
&
Vincenzo FuscoRadiation Oncology Department, IRCCS-CROB, via S. Pio 1, 85028, Rionero in Vulture (PZ), Italy
Pages 1099-1105 | Published online: 09 Jan 2014

References

  • Stupp R, Mason WP, van den Bent MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352(10), 987–996 (2005).
  • Brandes AA, Bartolotti M. Treatment decision in elderly patients with glioblastoma. Nat. Rev. Neurol. 8, 664–665 (2012).
  • Nghiemphu PL, Cloughesy T. Glioblastoma therapy in the elderly: one age does not fit all. Lancet Oncol. 13, 857–858 (2012).
  • Fiorentino A, Balducci M, Chiesa S, Fusco V. Elderly people with glioblastoma. Lancet Oncol. 13, e327–e328 (2012).
  • Yovino S, Grossman SA. Treatment of glioblastoma in ‘elderly’ patients. Curr. Treat. Opin. Oncol. 12, 253–262 (2011).
  • Iwamoto FM, Cooper AR, Reiner AS et al. Glioblastoma in elderly: the Memorial-Sloan Kettering Cancer Center experience (1997–2007). Cancer 115(16), 3758–3766 (2009).
  • Sahebjam S, McNamara M, Mason WP. Management of glioblastoma in the elderly. Clin. Adv. Hematol. Oncol. 10, 379–386 (2012).
  • Balducci M, Fiorentino A, De Bonis P et al. Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional Phase II studies. Med. Oncol. 29(5), 3478–3483 (2012).
  • Fiorentino A, Caivano R, Chiumento C et al. Comorbidity assessment and adjuvant radiochemotherapy in elderly affected by glioblastoma. Med. Oncol. 29(5), 3467–3471 (2012).
  • de Barros Pontes L, Karnakis T, Fleury Malheiros SM et al. Glioblastoma: approach to treat elderly patients. Einstein 10(4), 512–518 (2012).
  • Mangiola A, De Bonis P, Guerriero M, Popucci A, Anile C. Glioblastoma multiforme in the elderly: a therapeutic challenge. J. Neurooncol. 76(2), 159–163 (2006).
  • Ewelt C, Goeppert M, Rapp M, Steiger HJ, Stummer W, Sabel M. Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival. J. Neurooncol. 103(3), 611–618 (2011).
  • Wick W, Platten M, Meisner C et al. Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, Phase 3 trial. Lancet Oncol. 13, 707–715 (2012).
  • Scott J, Tsai YY, Chinnaiyan P, Yu HH. Effectiveness of radiotherapy for elderly patients with glioblastoma. Int. J. Rad. Oncol. Biol. Phys. 81(1), 206–210 (2011).
  • Keim-Guibert F, Chinot O, Taillandier L et al. Radiotherapy for glioblastoma in elderly. N. Engl. J. Med. 356, 1527–1535 (2007).
  • Bauman GS, Gaspar LE, Fisher BJ et al. A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys. 29, 835–839 (1994).
  • Roa W, Brasher PM, Bauman G et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J. Clin. Oncol. 22(9), 1593–1598 (2004).
  • Lawrence YR, Li Xa, el Naga I et al. Radiation dose-volume effect in the brain. Int. J. Radiat. Oncol. Biol. Phys. 76, S20–27 (2010).
  • Galanis E, Buckner J. Chemotherapy for high-grade gliomas. Br. J. Cancer 82, 1371–1380 (2000).
  • Fine HA, Dear KBG, Loeffler JS, Black PM, Canellos GP. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71, 2585–2597 (1993).
  • Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359,1011–1018 (2002).
  • Hirose Y, Berger MS, Pieper RO. P53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells. Cancer. Res. 61, 1957–1963 (2001).
  • Chamberlain MC, Chalmers L. A pilot study of primary temozolomide chemotherapy and deferred radiotherapy in elderly patients with glioblastoma. J. Neurooncol. 82, 207–209 (2007).
  • Laigle-Donadey F, Figarella-Branger D, Chinot O et al. Up-front temozolomide in elderly patients with glioblastoma. J. Neurooncol. 99, 89–94 (2010)
  • Chinot OL, Barrie M, Barrie M et al. Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations. Cancer 100(10), 2208–2214 (2004).
  • Gallego-Perez-Larraya J, Ducray F, Chinot O et al. Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF Phase II trial. J. Clin. Oncol. 29, 3050–3055(2011).
  • Chargari C, Feuvret L, Bauduceau O et al. Treatment of elderly patients with glioblastoma: from clinical evidence to molecular highlights. Cancer Treat. Rev. 38, 988–995 (2012).
  • Glantz M, Chamberlain M, Liu Q et al. Temozolomide as an alternative to irradiation for elderly patients with new diagnosed malignant gliomas. Cancer 97(9), 2262–2266 (2003).
  • Malmstrom A, Gronberg BH, Marosi C et al. Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, Phase 3 trial. Lancet Oncol. 13, 916–926 (2012).
  • De Bonis P, Mangiola A, Pompucci A, Porso M, Anile C. High-grade glioma: elderly patients, older treatments. Expert Rev. Neurother. 12(11), 1293–1296 (2012).
  • Stupp R, Hegi ME, Mason WP et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised Phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 10, 459–466 (2009).
  • Floyd SR, Kasper EM, Uhlmann EJ et al. Hypofractionated radiotherapy and stereotactic boost with concurrent and adjuvant temozolomide for glioblastoma in glioblastoma status elderly patients – early results of a phase II trial. Front Oncol. 2, 122 (2012).
  • Fiorentino A, Balducci M, De Bonis P et al. Can elderly patients with newly diagnosed glioblastoma be enrolled in radiochemotherapy trials? Am. J. Clin. Oncol. doi:10.1097/COC.0b013e3182868ea2 (2013) (Epub ahead of print).
  • Fiorentino A, Chiumento C, Caivano R et al. Adjuvant radiochemotherapy in the elderly affected by glioblastoma: single-institution experience and literature review. Radiol. Med. 118(5), 870–881 (2012).
  • Combs SE, Wagner J, Bischof M et al. Postoperative treatment of primary gioblastoma multiforme with radiation and concomitant temozolomide in elderly patients. Int. J. Radiat. Oncol. Biol. Phys. 70, 987–992 (2008).
  • Minniti G, De Sanctis V, Muni R et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. J. Neurooncol. 88, 97–103 (2008).
  • Brandes AA, Franceschi E, Tosoni A et al. Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. Cancer 115, 3512–3518 (2009).
  • Gerstein J, Franz K, Steinbach JP et al. Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma. Radiother. Oncol. 97(3), 382–386 (2010).
  • Fiorica F, Berretta M, Colosimo C et al. Glioblastoma in elderly patients: safety and efficacy of adjuvant radiotherapy with concomitant temozolomide. Arch. Gerontol. Geriatr. 51(1), 31–35 (2010).
  • Kimple RJ, Grabowski S, Papez M, Collichio F, Ewend MG, Morris DE. Concurrent temozolomide and radiation, a reasonable option for elderly patients with glioblastoma multiforme? Am. J. Clin. Oncol. 33, 265–270 (2010).
  • Dirier A, Abacioglu MU, Okkan S et al. Radiotherapy with or without temozolomide in elderly glioblastoma patients: treatment results and prognostic factor. J. Clin. Oncol. 28, 15s (2010).
  • Minniti G, Lanzetta G, Scaringi C et al. Phase II study of short-course radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma. Int. J. Radiat. Oncol. Biol. Phys. 83, 93–99 (2012).
  • Cao JQ, Fisher BJ, Bauman GS, Megyesi JF, Watling CJ, Macdonald DR. Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience. J. Neurooncol. 107, 395–405 (2012).
  • Soussain C, Ricard D, Fike JR, Mazeron JJ, Psimaras D, Delattre JY. CNS complications of radiotherapy and chemotherapy. Lancet 374, 1639–1651 (2009).
  • Brown PD, Jensen AW, Felten SJ et al. Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma. J. Clin. Oncol. 24, 5427–5433 (2006).
  • Balducci M, Chiesa S, Diletto B et al. Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study. Neuro. Oncol. 14(1), 79–86 (2012).
  • Holdhoff M, Rosner GL, Alcorn S, Grossman SA. ‘Elderlyrsquo; patients with newly diagnosed glioblastoma deserve optimal care. J. Neurooncol. 113(2), 343–344 (2013).
  • Fiorentino A, Fusco V. Elderly patients affected by glioblastoma treated with radiotherapy: the role of serum hemoglobin level. Int. J. Neurosci. 123(2), 133–137 (2013).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.